NCT06955845View on ClinicalTrials.gov

Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder

NAActive, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 6, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
PTSDPTSD - Post Traumatic Stress Disorder
Interventions
BEHAVIORAL

Eye Movement Desensitization and Reprocessing Therapy

Patients in this arm will receive weekly EMDR sessions for 6 weeks

DRUG

Selective serotonin reuptake inhibitors

The patients will receive an SSRI medication daily for 6 weeks. The dose will be titrated by the clinician.

Trial Locations (2)

25770

Combined Military Hospital, Nowshera

Department of Psychiatry, Combined Military Hospital Nowshera, Nowshera

All Listed Sponsors
collaborator

CMH Nowshera

UNKNOWN

lead

Asad Ullah Jan

OTHER_GOV

NCT06955845 - Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) Therapy Versus Selective Serotonin Reuptake Inhibitors (SSRIs) in the Treatment of Post-Traumatic Stress Disorder | Biotech Hunter | Biotech Hunter